Učitavanje...

Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis: Clinical Profiles of the Once-Weekly and Once-Daily Dosing Formulations

OBJECTIVE: The objective of this review is to present the clinical profiles of the once-weekly and once-daily dosing formulations of alendronate and risedronate, the 2 bisphosphonates currently available in the United States for the prevention and treatment of postmenopausal osteoporosis. DATA SOURC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Emkey, Ronald
Format: Artigo
Jezik:Inglês
Izdano: Medscape 2004
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1435623/
https://ncbi.nlm.nih.gov/pubmed/15520628
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!